Genmab (GMAB)
(Delayed Data from NSDQ)
$23.53 USD
-0.18 (-0.76%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $23.52 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC11/6/24 |
---|---|
Current Quarter | 0.31 |
EPS Last Quarter | 0.22 |
Last EPS Surprise | -24.14% |
ABR | 2.28 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.27 |
Next Year | 1.50 |
EPS (TTM) | 1.21 |
P/E (F1) | 18.48 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 842.06M | 890.40M | 3.15B | 3.74B |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 874.07M | 953.71M | 3.24B | 3.84B |
Low Estimate | 793.58M | 857.73M | 3.05B | 3.48B |
Year ago Sales | 692.80M | 675.29M | 2.39B | 3.15B |
Year over Year Growth Est. | 21.54% | 31.86% | 31.66% | 18.58% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.31 | 0.37 | 1.27 | 1.50 |
# of Estimates | 7 | 6 | 9 | 8 |
Most Recent Consensus | 0.35 | 0.41 | 1.39 | 1.58 |
High Estimate | 0.35 | 0.59 | 1.58 | 1.99 |
Low Estimate | 0.25 | 0.29 | 1.13 | 1.27 |
Year ago EPS | 0.47 | 0.36 | 1.18 | 1.27 |
Year over Year Growth Est. | -34.04% | 2.78% | 7.63% | 17.65% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 5 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.31 | 0.37 | 1.27 | 1.50 |
7 Days Ago | 0.31 | 0.37 | 1.27 | 1.50 |
30 Days Ago | 0.31 | 0.37 | 1.27 | 1.50 |
60 Days Ago | 0.28 | 0.30 | 1.15 | 1.47 |
90 Days Ago | 0.27 | 0.28 | 1.11 | 1.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.31 | 0.37 | 1.27 | 1.50 |
Zacks Consensus Estimate | 0.31 | 0.37 | 1.27 | 1.50 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.22 | 0.16 | 0.36 | 0.47 | NA |
Estimate | 0.29 | 0.16 | 0.34 | 0.34 | NA |
Difference | -0.07 | 0.00 | 0.02 | 0.13 | 0.02 |
Surprise | -24.14% | 0.00% | 5.88% | 38.24% | 5.00% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more